Misuzu Hoshino

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Misuzu Hoshino is an author at Japan Bio Products (Japan) specializing in neuromuscular disorder pharmacotherapy, spinal muscular atrophy pharmacotherapy, and antisense rnas.

ORCID

Publications per year

2022–2023

Publications

Real-world safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 401 Japanese patients: results from an interim analysis of post-marketing surveillance

Yosuke Tachibana, Sakura Takasaki, Misuzu Hoshino et al. · International Journal of Neuroscience · 2022 · 10 citations

Medicine, Neurology, Pharmacotherapy +17

Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan

Yosuke Tachibana, Ryusuke Sato, Haruki Makioka et al. · International Journal of Neuroscience · 2023 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

1–2 of 2